Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Exagen Inc shares valued at $375,598 were sold by ABALLI JOHN on Oct 16 ’25. At $11.82 per share, ABALLI JOHN sold 31,787 shares. The insider’s holdings dropped to 714,427 shares worth approximately $3.45 million following the completion of this transaction.
Also, Black Jeffrey G. sold 20,466 shares, netting a total of over 200,362 in proceeds. Following the sale of shares at $9.79 each, the insider now holds 269,026 shares.
Before that, NMSIC Co-Investment Fund, L.P. had sold 350,000 shares from its account. In a trade valued at $1,155,000, the 10% Owner traded Exagen Inc shares for $3.30 each. Upon closing the transaction, the insider’s holdings decreased to 350,000 shares, worth approximately $8.5 million.
As published in their initiating research note from B. Riley Securities on September 11, 2025, Exagen Inc [XGN] has been a Buy and the price target has been revised to $15. Analysts at KeyBanc Capital Markets upgraded the stock from ‘”a Sector weight”‘ to ‘”an Overweight”‘ outlook in a report released in late July. As of July 23, 2025, Craig Hallum has initiated its “Buy” rating for XGN. Earlier on August 05, 2022, KeyBanc Capital Markets downgraded its rating. Their new recommendation was “a Sector weight” for XGN stock which previously was a “an Overweight”.
Analyzing XGN Stock Performance
On last trading session, Exagen Inc [NASDAQ: XGN] plunged -5.11% to $4.83. The stock’s lowest price that day was $4.82, but it reached a high of $5.09 in the same session. During the last five days, there has been a drop of approximately -21.72%. Over the course of the year, Exagen Inc shares have jumped approximately 61.00%.
Support And Resistance Levels for Exagen Inc (XGN)
RSI (Relative Strength Index) is 21.21 on the 14-day chart, showing oversold technical sentiment.
Is Exagen Inc subject to short interest?
Stocks of Exagen Inc saw a sharp rise in short interest on 2025-12-31 jumping by 0.3 million shares to 1.08 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 0.78 million shares. A jump of 27.53% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.61 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.61.
Which companies own the most shares of Exagen Inc (XGN)?
In terms of Exagen Inc share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, up nearly 194.7% from the previous closing price of $5.09. Analysts anticipate Exagen Inc stock to reach 15 by 2026, with the lowest price target being 10. In spite of this, 2 analysts ranked Exagen Inc stock as Buy at the end of 2026. On October 15, 2021, Cowen assigned a price target of “an Outperform” to the stock and resumed coverage with a $26.
